Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
P11245
UPID:
ARY2_HUMAN
Alternative names:
Arylamide acetylase 2; N-acetyltransferase type 2; Polymorphic arylamine N-acetyltransferase
Alternative UPACC:
P11245; O43637; O60654; O60655; Q13146; Q16697; Q2MLE4; Q2MLF5; Q2MLG8; Q2MLJ6; Q2MLK4; Q2MLK6; Q2MLN7; Q6LET4; Q86XS0; Q86XS1; Q96KY8; Q96T64; Q96T65; Q9H220
Background:
Arylamine N-acetyltransferase 2, known by alternative names such as Arylamide acetylase 2, N-acetyltransferase type 2, and Polymorphic arylamine N-acetyltransferase, plays a crucial role in the detoxification of various drugs. It catalyzes the N- or O-acetylation of arylamine and heterocyclic amine substrates, contributing to the bioactivation of several carcinogens.
Therapeutic significance:
Understanding the role of Arylamine N-acetyltransferase 2 could open doors to potential therapeutic strategies. Its involvement in drug detoxification and bioactivation of carcinogens highlights its importance in pharmacogenomics and cancer research.